TALPHERA, INC. Proceeds from Long-Term Debt Issued
TALPHERA, INC. (TLPH) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2021-03-15
- TALPHERA, INC. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- TALPHERA, INC. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- TALPHERA, INC. proceeds from issuance of long-term debt for the quarter ending 2019-12-31 was $0.00.
- TALPHERA, INC. proceeds from issuance of long-term debt for the quarter ending 2019-09-30 was $0.00.
- TALPHERA, INC. proceeds from issuance of long-term debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- TALPHERA, INC. proceeds from issuance of long-term debt for fiscal 2019 was $25.00M.
- TALPHERA, INC. proceeds from issuance of long-term debt for fiscal 2018 was $0.00.
- TALPHERA, INC. proceeds from issuance of long-term debt for fiscal 2014 was $10.00M, a 33.15% decline from fiscal 2013.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 72 month | Proceeds from Issuance of Long-term Debt 75 month | Proceeds from Issuance of Long-term Debt 78 month | Proceeds from Issuance of Long-term Debt 81 month | Proceeds from Issuance of Long-term Debt 84 month | Proceeds from Issuance of Long-term Debt 87 month | Proceeds from Issuance of Long-term Debt 90 month | Proceeds from Issuance of Long-term Debt 93 month | Proceeds from Issuance of Long-term Debt 96 month | Proceeds from Issuance of Long-term Debt 99 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $0.00 10-K · filed 2021-03-15 | |||||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | ||||||||||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | |||||||||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $25.00M 10-K · filed 2021-03-15 | |||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $25.00M 10-Q · filed 2020-11-05 | ||||||||||||
| 2019-06-30 | $25.00M 10-Q · filed 2020-08-10 | |||||||||||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 | |||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 derived: sum of 2 quarters · filed 2017-03-03 | $10.00M 10-K · filed 2017-03-03 | |||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $10.00M 10-Q · filed 2015-11-03 | ||||||||||||
| 2014-06-30 | $10.00M 10-Q · filed 2015-08-04 | |||||||||||||
| 2013-12-31 | $14.96M 10-K · filed 2016-03-07 | |||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 99 month − 10-Q 96 month · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $0.00 derived: sum of 3 quarters · filed 2013-11-05 | $0.00 derived: sum of 4 quarters · filed 2013-11-05 | $32.38M 10-Q · filed 2013-11-05 | |||||||||
| 2013-06-30 | $0.00 derived: 10-Q 96 month − 10-Q 93 month · filed 2013-08-12 | $0.00 derived: sum of 2 quarters · filed 2013-08-12 | $0.00 derived: sum of 3 quarters · filed 2013-08-12 | $0.00 derived: sum of 4 quarters · filed 2013-08-12 | $32.38M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | $0.00 derived: 10-Q 93 month − 10-K 90 month · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2013-05-08 | $0.00 derived: sum of 3 quarters · filed 2013-05-08 | $0.00 derived: sum of 4 quarters · filed 2013-05-08 | $32.38M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $0.00 derived: 10-K 90 month − 10-Q 87 month · filed 2013-03-12 | $0.00 derived: sum of 2 quarters · filed 2013-03-12 | $0.00 derived: sum of 3 quarters · filed 2013-03-12 | $0.00 derived: sum of 4 quarters · filed 2013-03-12 | $32.38M 10-K · filed 2013-03-12 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 87 month − 10-Q 84 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $0.00 derived: sum of 3 quarters · filed 2012-11-06 | $10.00M derived: sum of 4 quarters · filed 2014-03-17 | $32.38M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 84 month − 10-Q 81 month · filed 2012-08-10 | $0.00 derived: sum of 2 quarters · filed 2012-08-10 | $10.00M derived: sum of 3 quarters · filed 2014-03-17 | $10.00M derived: sum of 4 quarters · filed 2014-03-17 | $32.38M 10-Q · filed 2012-08-10 | |||||||||
| 2012-03-31 | $0.00 derived: 10-Q 81 month − 10-K 78 month · filed 2012-05-09 | $10.00M derived: sum of 2 quarters · filed 2014-03-17 | $10.00M derived: sum of 3 quarters · filed 2014-03-17 | $32.38M 10-Q · filed 2012-05-09 | ||||||||||
| 2011-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $10.00M derived: sum of 2 quarters · filed 2014-03-17 | $19.76M 10-K · filed 2014-03-17 | $32.38M 10-K · filed 2012-03-23 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $9.76M 10-Q · filed 2012-11-06 | $22.38M 10-Q · filed 2011-11-08 | |||||||||||
| 2011-06-30 | $9.76M 10-Q · filed 2012-08-10 | $22.38M 10-Q · filed 2011-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |